Drug Discovery and Development Industry Market Research Reports in Japan, May 2013

Biota Holdings Ltd. - Company Report for Year 2012

• Company report
• February 2012
• 5 pages

... And costs under the barda program. Delivering our manufacturing facilities plan, which has to occur before the clinical studies, will also incur significant expenditure and much of that work is already ...

• Industries: Drug Discovery and Development
• Countries: United States, Japan

Biota Holdings Ltd. - Company Report for Year 2012

• Company report
• February 2012
• 5 pages
• by Corporation

• Industries: Drug Discovery and Development
• Countries: United States, Japan

Vectura Group PLC - Annual Report 2012

• Company report
• March 2012
• 17 pages

... To receive up to a further $32m upon achievement of future pre-determined development milestones vr506 development on-going with two multi-centre, international clinical trials currently in progress; one ...

• Industries: Drug Discovery and Development
• Countries: Japan, Europe, United States

Investor presentation: Drug Discovery and Development in India, The United States and Japan for Year 2012

• Company report
• March 2012
• 35 pages
• by Corporation

... Engaged in manufacture and supply of apis, generics, specialty pharmaceuticals and life science ingredients. It also provides services in contract manufacturing and drug discovery and development ...

• Industries: Drug Discovery and Development
• Countries: India, United States, Japan

Company Report: Drug Discovery and Development in The United States and Japan for Year 2011

• Company report
• December 2011
• 3 pages
• by Corporation

... Collaboration company that uses innovative clinical development design to accelerate and increase value of internal and drug development programs by advancing them through the drug discovery and development ...

• Industries: Drug Discovery and Development
• Countries: United States, Japan

Company Report: Drug Discovery and Development in The United States and Japan for Year 2011

• Company report
• September 2011
• 3 pages
• by Corporation

... Furiex furiex pharmaceuticals is a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of internal and partnered drug programs ...

• Industries: Drug Discovery and Development
• Countries: United States, Japan

Investor presentation: Drug Discovery and Development in Canada, The United States and Japan for Year 2011

• Company report
• March 2011
• 30 pages

... Y across all business segments Continue to be the preferred outsourcing partner for global pharmaceuticals companies in niche areas of injectibles and drug discovery Focus on regulated markets ...

• Industries: Drug Discovery and Development
• Countries: Canada, United States, Japan

Company Report: Clinical Trial in The United States and Japan for Year 2011

• Company report
• March 2011
• 9 pages

... Basis). In the cro business, linical specializes in the most vital stages of clinical trials of phase ii and iii studies including major activities such as monitoring, quality control, and consulting ...

• Industries: Drug Discovery and Development
• Countries: United States, Japan, World

BioGaia AB - Investment Analysis, March 2011

• Company report
• March 2011
• 13 pages

... That the registered trials reach completion or are successfully reported in the register or the scientific literature. When clinical trials results of significance to the company s business do become available, bio ...

• Industries: Drug Discovery and Development
• Countries: Japan

Company Report: Drug Discovery and Development in Japan for Year 2011

• Company report
• March 2011
• 14 pages
• by Corporation

... Invested in clinical trials approximately $1.4 Million more than in the same quarter last year. These costs will continue as planned in the second quarter of 2012. The decrease is also attributable ...

• Industries: Drug Discovery and Development
• Countries: Japan

Company Report: Clinical Trial in Japan for Year 2012

• Company report
• April 2012
• 11 pages

... Will increase as we promote research and development, including clinical trials, for developing pipelines. We have secured these funds by public offering upon stock listing, and we will make efforts to ensure ...

• Industries: Drug Discovery and Development
• Countries: Japan

Investor presentation: Drug Discovery and Development in India, The United States and Japan for Year 2012

• Company report
• March 2012
• 31 pages
• by Corporation

• Industries: Drug Discovery and Development
• Countries: India, United States, Japan

Company Report: Clinical Trial in Japan and The United States for Year 2012

• Company report
• November 2012
• 3 pages
• by Corporation

... Stage product cands; progress of product cands in clinical trials and regulatory approvals as it relates to receiving future milestone payments; inability of our existing collaborators to effectively ...

• Industries: Drug Discovery and Development
• Countries: Japan, United States

Allotment - Investment Analysis, December 2012

• Company report
• December 2012
• 5 pages

... Potential. Building a pipeline with multiple drug cands for underserved markets with orphan-like indications and lower competition will enable symbio to achieve steady growth. As such, sym ...

• Industries: Drug Discovery and Development
• Countries: Japan

Investor presentation: Drug Discovery and Development in Denmark and Japan for Year 2012

• Company report
• December 2012
• 12 pages
• by Corporation

... Include, among others, risks associated with product discovery and development, uncertainties related to the outcome of clinical trials, slower than expected rates of patient recruitment, unforeseen safety ...

• Industries: Drug Discovery and Development
• Countries: Denmark, Japan

Fuso Pharmaceutical Industries Ltd. - Company Report for Year 2013

• Company report
• March 2013
• 28 pages

... Costs were to increase as multiple clinical trials are conducted simultaneously). 3Dm was planning on starting clinical trials for several pipeline applications, such as its alveolar bone reconstruction ...

• Industries: Drug Discovery and Development
• Countries: Japan, United States, South Korea

Company Report: Drug Discovery and Development in Japan for Year 2012

• Company report
• August 2012
• 2 pages

... And release of new drugs. In addition, the japanese government implements initiatives to stimulate clinical trials aiming at promoting innovative drug development and reducing the so-called "drug lag ...

• Industries: Drug Discovery and Development
• Countries: Japan

Fuso Pharmaceutical Industries Ltd. - Company Report for Year 2012

• Company report
• September 2012
• 32 pages

... As a treatment for spontaneous bone cancer through pre-clinical trials. The company added this project could have significant impact on worldwide cancer stem cell research, mirna research and many other clinical ...

• Industries: Drug Discovery and Development
• Countries: Japan

Company Report: Clinical Trial in Japan for Year 2012

• Company report
• June 2012
• 12 pages

... As to our second pipeline, dental bone filler (tdm-711), our subsidiary acquired ide approval from the us food and drug administration in july, 2011 and the clinical trial started at forsyth institute ...

• Industries: Drug Discovery and Development
• Countries: Japan

Fuso Pharmaceutical Industries Ltd. - Company Report for Year 2012

• Company report
• June 2012
• 29 pages

... clinical trials for tdm-711 have been performed at forsyth institute affiliated with harvard school of dental medicine since february 2012. According to the announcement, the company has completed ...

• Industries: Drug Discovery and Development
• Countries: Japan

Fuso Pharmaceutical Industries Ltd. - Company Report for Year 2012

• Company report
• April 2012
• 39 pages

• Industries: Drug Discovery and Development
• Countries: Japan

Clinical Trial in Japan : Innovation and Technology Trends

• Industry report
• April 2013
• 32 pages

... And insurance for clinical research besides trials a lot of clinical research not covered by the pharmaceutical affairs act is conducted in many education-related hospitals such as university hospitals ...

• Industries: Drug Discovery and Development
• Countries: Japan

Clinical Trial in Japan : Innovation and Technology Trends

• Industry report
• March 2012
• 20 pages

... trials are regarded appropriate demand if criteria are met available in us,uk, ge,fr opinion evaluation of necessity of clinical trials and other studies clinical trials csimc reflection on drug ...

• Industries: Drug Discovery and Development
• Countries: Japan

The Japanese Clinical Trial Market : Innovation and Technology Trends

• Industry report
• April 2011
• 25 pages

... In the country at an affordable price pakistan and india drug information association www.Diahome.Org 5 stimulation of pediatric trials in japan Government is seriously trying to promote clinical trials 5 ...

• Industries: Drug Discovery and Development
• Countries: Japan

The Japanese Clinical Trial Market : Innovation and Technology Trends

• Industry report
• October 2012
• 21 pages
• by Non Governmental Organization (NGO)

... Standards Summary: Using cdisc standards can save significant time and cost, especially when implemented in the early stages of the study Opportunities for an additional impact on clinical ...

• Industries: Drug Discovery and Development
• Countries: World, Japan

Clinical Trial in China, Japan and South Korea : Innovation and Technology Trends

• Industry report
• January 2012
• 6 pages

... Companies Both as a location for clinical trials and a market for novel therapies. That potential is tempered by the daunting regulatory requirements for pharmaceutical products in china Requirements ...

• Industries: Drug Discovery and Development
• Countries: China, Japan, South Korea

The Japanese Clinical Trial Market : Innovation and Technology Trends

• Industry report
• March 2012
• 223 pages

... clinical trials. The medium range plan includes the International strategic plan As the basic policy for the agency S international activities and the already developed Pmda vision ...

• Industries: Drug Discovery and Development
• Countries: Japan

Clinical Trial in The United States and Japan : Innovation and Technology Trends

• Industry report
• November 2011
• 75 pages

... Overview of phrma mrct kit white papers 23 survey of phrma companies about mrcts Extent to which companies are expanding regional reach of clinical trials Regions in which studies are being conducted ...

• Industries: Drug Discovery and Development
• Countries: United States, Japan, World

Clinical Research in Japan : Innovation and Technology Trends

• Industry report
• November 2011
• 28 pages

... Circlecopyrt cdisc 2011 Cdisc has established a suite of worldwide industry standards to support the electronic acquisition, exchange, submission and archiving of clinical research data and metadata to improve ...

• Industries: Drug Discovery and Development
• Countries: World, Japan

Clinical Trial in Japan : Innovation and Technology Trends

• Industry report
• September 2011
• 59 pages

... Increase in multinational studies and asian studies z change in trend of new drug development ( response to unmet medical needs ) z clinical trials are requiring larger number of patients z investigator ...

• Industries: Drug Discovery and Development
• Countries: Japan